The majority of women who underwent a lumpectomy or a mastectomy reported not feeling fully informed of their treatment options, but the use of Web-based decision aids can help patients become informed, according to results of 2 new studies published in the Journal of the American College of Surgeons.
The majority of women who underwent breast cancer operations reported not feeling fully informed of their treatment options, but the use of Web-based decision aids can help patients become informed, according to results of 2 new studies published in the Journal of the American College of Surgeons.
Breast cancer is the second most prevalent type of cancer in women in the United States, with over 230,000 diagnosed annually. For many breast cancer patients, choosing a treatment option is daunting. The first of the pair of studies sought to determine how patients receive their information to identify opportunities for improvement.
"Women diagnosed with breast cancer often describe the process of treatment decision making as bewildering and worrisome," wrote the authors. "Patients who do not feel completely informed about their surgical options may make choices that are suboptimal or regretted later."
The authors of the study conducted a nationwide survey between June 13, 2016, and June 24, 2016, among women who reported being surgically treated by lumpectomy only, mastectomy only, or both procedures for the treatment of breast cancer. Of the 487 women, 215 had a lumpectomy only, 140 had a mastectomy only, and 132 underwent both procedures.
Results showed that only 47% of lumpectomy patients, 67% of mastectomy patients, and 28% of both-surgeries patients said they felt completely informed about their treatment options prior to their surgeries. One-third of lumpectomy and mastectomy patients and one-fifth of both-surgeries patients indicated that making a quick decision for treatment was more important than researching all of their options. The majority of all 3 groups said they wished they had more time to explore different treatment options.
For sources of information, 66% of lumpectomy patients, 64% of mastectomy patients, and 76% of both-surgeries patients said that once their breast cancer surgeon recommended a surgery, they did not feel the need to research other options.
"This survey shows that a large portion of American women who had surgery for breast cancer did not feel completely informed about their treatment options," wrote the authors. "All healthcare providers should strive to create the ideal cancer care system where patients have an awareness of all treatment options and the risks and benefits associated with each."
According to the authors, efforts should include:
Also examining how patients received information about their treatment options, a second research team found that decision aids were more effective in informing patients than standard cancer information websites.
Between April 2016 and June 2016, the authors randomized women with stage 0 to stage III breast cancer, who were considering an operation within the University of Wisconsin breast program, to receive a link to selected standard websites, such as the National Cancer Institute, versus Web-based decision aids. According to the authors, the decision aid utilizes static, didactic information written for an eighth-grade reading level and clinical video vignettes. After receiving the links and reviewing the information, patients filled out a questionnaire in the clinic prior to their first surgical consultation. Using a breast cancer decision quality instrument, the authors measured patient knowledge.
Results showed that patients who received a link to the decision aid showed higher overall knowledge compared to patients who received links to standard websites. These patients were also more likely to know that waiting a few weeks to make a treatment decision would not affect survival (72% versus 54%).
"Although patients found receipt of any pre-consultation information helpful, the decision aid resulted in improved knowledge over standard websites and effectively conveyed that there is time to make a breast cancer surgery decision," concluded the authors. "Decreasing the urgency patients feel may improve the quality of patient-surgeon interactions and lead to more informed decision-making."
Sarcoma Care: Biomarker Advancements Shape the Future
October 24th 2024At the regional Institute for Value-Based Medicine® event in Boston, Vinayak Venkataraman, MD, medical oncologist at Dana-Farber Cancer Institute and Harvard Medical School, was a panelist for the discussion, “Recent Advancements in Identifying Predictive Biomarkers for Sarcomas."
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Combatting Misconceptions of Clinical Trials to Improve Patient Participation
October 16th 2024There are many misconceptions patients might have about clinical trials that prevent them from participating, and it’s important to understand what they are in order to overcome them, said Terry L. Keys, of University of Kentucky Markey Cancer Center.
Read More
Creating Equitable Cancer Care for Americans of Asian and Pacific Islander Heritage
October 15th 2024Naoto T. Ueno, MD, PhD, FACP, of the University of Hawai’I Cancer Center outlines the underrepresentation in clinical trials, the lack of permanent medical oncologists, and issues of trust affecting care for the populations living in Hawaii.
Read More